RNF216-IT1: A Drug Target / Disease Biomarker (G100874342)

Target Name: RNF216-IT1

NCBI ID: G100874342

RNF216-IT1

Other Name(s): RNF216 intronic transcript 1

RNF216-IT1: A Drug Target / Disease Biomarker

RNA-Nucleic Acid (RNA) factors are a family of proteins that play a crucial role in various cellular processes. One of the RNA factors that has garnered significant interest in recent years is the RNA-Nucleic Acid (RNA-NA) protein, also known as RNF216. RNF216 is a protein that is expressed in various tissues and cells throughout the body, and it has been shown to play a role in a number of cellular processes, including DNA replication, transcription, and RNA processing.

One of the unique features of RNF216 is its ability to interact with DNA in a highly specific and efficient manner. This interaction allows RNF216 to access and manipulate specific regions of the DNA, allowing it to participate in a wide range of cellular processes. In addition, RNF216 has been shown to play a role in regulating gene expression, which is a critical aspect of cellular development and function.

The RNA-NA protein has also been shown to play a role in the regulation of cellular signaling pathways. In particular, RNF216 has been shown to interact with the protein Myc, which is a key regulator of the PI3K/Akt signaling pathway. This interaction allows RNF216 to influence the activity of Myc and to play a role in the regulation of cellular signaling pathways.

In addition to its role in cellular signaling pathways, RNF216 has also been shown to play a role in the regulation of DNA replication. In particular, RNF216 has been shown to interact with the protein DnaB, which is a key component of the DNA replication machinery. This interaction allows RNF216 to influence the activity of DNAB and to play a role in the regulation of DNA replication.

The RNA-NA protein has also been shown to play a role in the regulation of RNA processing. In particular, RNF216 has been shown to interact with the protein SnRNA, which is a key regulator of RNA metabolism. This interaction allows RNF216 to influence the activity of SnRNA and to play a role in the regulation of RNA processing.

Overall, the RNA-NA protein, also known as RNF216, is a drug target (or biomarker) that has significant potential for the development of new therapeutics for a wide range of diseases. Its ability to interact with DNA and to play a role in the regulation of cellular signaling pathways, DNA replication, and RNA processing make it an attractive target for the development of new therapeutics. Additionally, its role in the regulation of cellular development and function also make it a potential target for the development of new therapeutics for the treatment of diseases such as cancer, neurodegenerative diseases, and genetic disorders.

Protein Name: RNF216 Intronic Transcript 1

The "RNF216-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF216-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets